Literature DB >> 29348706

Diagnosis and Treatment of Clostridium difficile Infection (CDI).

Dale N Gerding1,2, Thomas M File3,4, L Clifford McDonald5.   

Abstract

Early and accurate diagnosis is essential for optimal treatment of individuals with Clostridium difficile infection (CDI) and for implementation of effective infection control procedures. The decision about which diagnostic test to use is an important one that should be based on test sensitivity, specificity, and predictive value. The challenges of CDI go beyond rapid identification and management of symptomatic patients. Asymptomatic carriage has long been suspected in C. difficile transmission, but it may play a larger role than previously thought. Emerging information also shows that patients treated for CDI remain colonized for many weeks after symptom resolution. In fact, stool culture positivity increases during the first weeks following treatment completion. Treatments that reduce the duration and degree of asymptomatic shedding could have added benefit for reduced transmission.

Entities:  

Keywords:  CDI; Clostridium difficile; diagnostic test; treatment

Year:  2016        PMID: 29348706      PMCID: PMC5769958          DOI: 10.1097/IPC.0000000000000350

Source DB:  PubMed          Journal:  Infect Dis Clin Pract (Baltim Md)        ISSN: 1056-9103


  38 in total

Review 1.  Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review.

Authors:  Tim Planche; Adamma Aghaizu; Richard Holliman; Peter Riley; Jan Poloniecki; Aodhán Breathnach; Sanjeev Krishna
Journal:  Lancet Infect Dis       Date:  2008-11-01       Impact factor: 25.071

Review 2.  Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.

Authors:  Dimitri Drekonja; Jon Reich; Selome Gezahegn; Nancy Greer; Aasma Shaukat; Roderick MacDonald; Indy Rutks; Timothy J Wilt
Journal:  Ann Intern Med       Date:  2015-05-05       Impact factor: 25.391

3.  Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease.

Authors:  Matthew D Neal; John C Alverdy; Daniel E Hall; Richard L Simmons; Brian S Zuckerbraun
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

4.  Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.

Authors:  Stuart Johnson; Thomas J Louie; Dale N Gerding; Oliver A Cornely; Scott Chasan-Taber; David Fitts; Steven P Gelone; Colin Broom; David M Davidson
Journal:  Clin Infect Dis       Date:  2014-05-05       Impact factor: 9.079

5.  Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals.

Authors:  Becky A Miller; Luke F Chen; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

6.  Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.

Authors:  Ilan Youngster; George H Russell; Christina Pindar; Tomer Ziv-Baran; Jenny Sauk; Elizabeth L Hohmann
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

7.  Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors:  Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal:  N Engl J Med       Date:  2013-01-16       Impact factor: 91.245

8.  Neutralization of Clostridium difficile toxin by Clostridium sordellii antitoxins.

Authors:  T W Chang; S L Gorbach; J B Bartlett
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

9.  Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.

Authors:  D G Teasley; D N Gerding; M M Olson; L R Peterson; R L Gebhard; M J Schwartz; J T Lee
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321

10.  Asymptomatic Clostridium difficile colonisation and onward transmission.

Authors:  David W Eyre; David Griffiths; Alison Vaughan; Tanya Golubchik; Milind Acharya; Lily O'Connor; Derrick W Crook; A Sarah Walker; Tim E A Peto
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more
  9 in total

Review 1.  Advances in the diagnosis and treatment of Clostridium difficile infections.

Authors:  Zhong Peng; Lifen Ling; Charles W Stratton; Chunhui Li; Christopher R Polage; Bin Wu; Yi-Wei Tang
Journal:  Emerg Microbes Infect       Date:  2018-02-07       Impact factor: 7.163

2.  Assessing the effect of patient screening and isolation on curtailing Clostridium difficile infection in hospital settings.

Authors:  Sara Maghdoori; Seyed M Moghadas
Journal:  BMC Infect Dis       Date:  2017-06-02       Impact factor: 3.090

Review 3.  Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.

Authors:  Saeed S Banawas
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411

Review 4.  Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI.

Authors:  I Castro; M Tasias; E Calabuig; M Salavert
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

5.  Antibiotic Resistances and Molecular Characteristics of Clostridioides difficile in ICUs in a Teaching Hospital From Central South China.

Authors:  Xiujuan Meng; Xun Huang; Zhong Peng; Yaowang Wang; Sidi Liu; Cui Zeng; Juping Duan; Ximao Wen; Chenchao Fu; Anhua Wu; Chunhui Li
Journal:  Front Med (Lausanne)       Date:  2021-12-06

6.  Decreasing ICU-associated Clostridioides difficile infection through fluoroquinolone restriction, the FIRST trial: a study protocol.

Authors:  Nasia Safdar; Vishala Parmasad; Roger Brown; Pascale Carayon; Alexander Lepak; John C O'Horo; Lucas Schulz
Journal:  BMJ Open       Date:  2021-06-29       Impact factor: 2.692

7.  Update in Infectious Diseases 2019.

Authors:  F J Candel; C M Rico; I Díaz de la Torre; B Laguna; J Martínez-Jordán; S Medrano; M C Escobar-Porcel; A López-Delgado; L López-González; J M Viñuela-Prieto; M Matesanz; J González Del Castillo; A Arribi
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

8.  GABAergic but not Antidepressant Medications Increase Risk for Clostridioides difficile Infection in a National Cohort of Veterans.

Authors:  Falak Lalani; Eric H Young; Rupesh M Panchal; Kelly R Reveles
Journal:  Open Forum Infect Dis       Date:  2020-08-13       Impact factor: 3.835

9.  Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation.

Authors:  Omar Ahmad; Timothy N Crawford; Vaneet Arora; Mitu Karki Maskey
Journal:  Infect Prev Pract       Date:  2021-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.